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Abstract
The tristetraprolin (TTP) family of zinc-finger proteins, TTP, BRF1 and BRF2, regulate the stability of a subset of mRNAs
containing 39UTR AU-rich elements (AREs), including mRNAs coding for cytokines, transcription factors, and proto-
oncogenes. To better understand the mechanism by which TTP-family proteins control mRNA stability in mammalian cells,
we aimed to identify TTP- and BRF1-interacting proteins as potential TTP-family co-factors. This revealed hnRNP F as a
prominent interactor of TTP and BRF1. While TTP, BRF1 and hnRNP F are all RNA binding proteins (RBPs), the interaction of
hnRNP F with TTP and BRF1 is independent of RNA. Depletion of hnRNP F impairs the decay of a subset of TTP-substrate
ARE-mRNAs by a mechanism independent of the extent of hnRNP F binding to the mRNA. Taken together, these findings
implicate hnRNP F as a co-factor in a subset of TTP/BRF-mediated mRNA decay and highlight the importance of RBP
cooperativity in mRNA regulation.
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Introduction
Messenger RNA (mRNA) degradation plays a critical role in
gene expression and cell metabolism by preventing overexpression
of proteins and by recycling nucleotides back to the cellular pools.
Tristetraprolin (TTP; also called Zfp36 and Tis11) is an RNA
binding protein that promotes rapid decay of a subset of mRNAs
containing AU-rich elements (AREs) in the 39 untranslated region
(UTR) [1–3]. While TTP does not appear to have catalytic
mRNA decay activity of its own, it interacts with several
components of the cellular mRNA decay machinery including
deadenylases, decapping factors, and exonucleases, to activate
decay of target mRNAs [4–7]. Two mammalian homologs of
TTP, BRF1 (also called Zfp36L1 and Tis11b) and BRF2 (also
called Zfp36L2 and Tis11d), appear to have similar RNA binding
properties and decay activities as TTP [5,8–11].
The post-transcriptional regulation of ARE-containing mRNAs
is complex. Upwards of 8% of mammalian mRNAs have
predicted AREs [12]. Many ARE mRNAs encode for highly
regulated factors, including cytokines, growth factors, transcription
factors, and early response genes [13,14]. At least twenty
confirmed and putative AU-rich element binding proteins
(AUBPs) have been identified thus far [13]. The proper regulation
of ARE mRNAs by AUBPs is important for homeostasis and
normal physiology, and misregulation is often associated with
detrimental effects to health and fitness. For example, TTP
knockout mice display severe autoimmune pathologies and
systemic inflammation that is attributable to increased levels of
the cytokine tumor necrosis factor-a (TNFa) due to slower decay
of its mRNA in macrophages from these animals [3,15]. Although
BRF1 and BRF2 knockout mice die at different stages of
development [16–18], tissue-specific conditional double mutants
develop leukemia and misregulate oncogenic transcription factor
Notch1, an ARE-containing mRNA [11]. Most often, AUBPs
target ARE mRNAs for degradation, but some AUBPs stabilize
mRNAs or regulate translation [13]. For example, HuR, a
member of the ELAV (embryonic lethal, abnormal vision) family
proteins, which is expressed ubiquitously in most cell types,
stabilizes many of the same ARE mRNAs that are targeted for
decay by other AUBPs [19,20]. How TTP and other AUBPs
identify and regulate specific substrate mRNAs amidst all the
ARE-containing mRNAs and other AUBPs in the cell is not well
understood.
The best characterized targets of TTP are the mRNAs for the
cytokines TNFa and GMCSF, which were identified in the initial
studies of the TTP knockout mouse [3,15,21]. Many additional
TTP substrate mRNAs have been discovered since [22–24], and
studies of the tandem zinc finger RNA binding domain of TTP has
demonstrated high binding affinity for the ARE nonameric
sequence UUAUUUAUU [25–28]. While TTP has been shown
to bind and regulate the decay of ARE mRNAs, there is evidence
from global mRNA analyses to suggest that TTP may also regulate
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many non-ARE containing mRNAs. For example, only 23 of 250
stabilized mRNAs in fibroblasts derived from TTP knockout mice
contain predicted TTP binding sites [24] and only ,10% of the
400 TTP-associated mRNAs identified in human dendritic cells
appeared to contain an ARE [23]. In contrasting studies, most of
the 128 mRNAs associated with TTP in mouse macrophage cells
contained the ARE pentamer sequence (AUUUA) [22], and 84%
of mRNAs associated with exogenous TTP in HEK293 cells
contained the UAUU sequence, the half-site of the preferred TTP
ARE nonameric binding sequence [29]. Thus, it appears that TTP
RNA binding is diverse and possibly not limited only to mRNAs
containing AREs. Moreover, the profile of TTP-associated
mRNAs may vary by tissue or cell-type. Additionally, not all
TTP-bound mRNAs require TTP for degradation [22], demon-
strating the complexity of TTP regulation of mRNA.
Given the abundance of predicted cellular ARE mRNAs, the
potential competition for binding to these transcripts from other
AUBPs, and the possibility that TTP associates with a large
number of non-ARE mRNAs in the cell, much remains to be
known about how TTP and its homologs BRF1 and BRF2
identifies and regulates target mRNAs. The objective of this study
was to identify proteins that exist in complex with TTP and BRF1
and might serve as TTP/BRF co-factors. Two prominent
interacting proteins were identified, hnRNP F and CAD. Given
the importance of hnRNP F as an abundant component of
messenger ribonucleoproteins (mRNPs) and previous implications
of hnRNP F in mRNA regulation we focused our studies on this
protein. We found that hnRNP F forms RNA-independent
complexes with TTP and BRF1 and that depletion of hnRNP F
impairs the decay of a subset of TTP mRNA substrates. Thus,
hnRNP F is a co-factor in degradation of a subset of TTP/BRF1-
target mRNAs.
Results
Identification of TTP and BRF1 interacting proteins
To gain mechanistic insight into the activity of TTP-family
proteins in ARE-mRNA decay, we decided to isolate proteins that
biochemically associate with TTP and BRF1. Human embryonic
kidney (HEK) 293T cell lines were generated to stably express
Flag-tagged TTP and BRF1 proteins under the control of a
tetracycline inducible promoter to allow for titration of exogenous
protein levels. Immunoprecipitation (IP) experiments were per-
formed from RNase-treated extracts of cells expressing Flag-
tagged TTP and BRF1 at levels similar to endogenous BRF1 (data
not shown). Interacting proteins were separated by SDS-PAGE
and visualized by silver staining. As seen in Figure 1A, TTP and
BRF1 displayed remarkably similar profiles of co-purifying
proteins with none of the co-purifying proteins observed from
cells expressing no Flag-tagged proteins. Mass spectrometry
analysis of individual gel bands identified 14-3-3e, hnRNP F
(heterogeneous nuclear ribonucleoprotein F), and CAD (carbam-
oyl-phosphate synthetase 2, aspartate transcarbamylase, and
dihydroorotase) as prominent TTP and BRF1 interacting proteins
(Figure 1A). In addition, Tubulin a, Tubulin b, and Hsp70 (heat
shock protein 70) were identified, but these proteins were excluded
from further study since we commonly find them co-purifying with
Flag-tagged proteins [6]. The identification of 14-3-3e, a
previously characterized TTP-interacting protein [30], validated
our experimental conditions.
To verify the identified protein interactions we performed co-IP
assays with exogenously expressed, tagged proteins from RNase-
treated HEK 293T extracts. As seen in Figure 1B, Myc-tagged
CAD, hnRNP F and 14-3-3e all co-purified with Flag-tagged TTP
and BRF1, but not with Flag-tagged HuR, an ARE-mRNA
stabilizing protein that served as a negative control (compare lanes
6, 7 to lane 8). An additional negative control, the RNA binding
protein hnRNP A1, did not co-IP with either TTP or BRF1
(bottom panel). Thus, we confirmed that exogenously expressed
CAD, hnRNP F and 14-3-3e exist in RNA-independent
complexes with TTP and BRF1.
hnRNP F complexes with TTP in stimulated macrophage
cells
hnRNP F is an RNA binding protein belonging to the hnRNP
superfamily and has previously been implicated in multiple steps of
Figure 1. hnRNP F and CAD form RNA-independent complexes
with TTP and BRF1. (A) Silver-stained SDS-polyacrylamide gels
showing proteins that co-purify with stably expressed Flag-tagged
TTP (left gel) or BRF1 (right gel) from extracts of T-REx HEK 293 cell lines
after RNase-treatment. Proteins co-purified from cells expressing no
Flag-tagged protein are run alongside as controls (lanes labeled ‘none’).
(B) Western blots of anti-Flag IP reactions from RNase-treated extracts of
HEK 293T cells transiently expressing Flag-tagged TTP (lane 6), BRF1
(lane 7), HuR (lane 8), or empty vector control (lane 5). Precipitates were
probed for the presence of co-expressed Myc-tagged CAD, hnRNP F, 14-
3-3e, or hnRNP A1 as indicated. Lanes 1–4 shows 5% of the total extract
for each IP reaction.
doi:10.1371/journal.pone.0100992.g001
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mRNA metabolism and gene expression regulation [31,32],
including repression of translation in D. melanogaster [33] and
translation regulation of neuronal mRNAs [34]. Given the overlap
between known functions of TTP-family proteins and hnRNP F,
we focused on hnRNP F for the remainder of this study; the
potential role of CAD in TTP/BRF1 function is a topic for future
studies.
To test whether endogenous TTP and hnRNP F associate in a
biochemical complex, we took advantage of the mouse macro-
phage cell line, RAW264.7 (hereafter called RAW), in which TTP
expression is induced upon treatment with lipopolysaccharide
(LPS) (Figures 2A and B, left panels). As seen in the co-IP
experiments in Figures 2A and 2B, endogenous hnRNP F can be
detected to co-purify with TTP when TTP is induced after 2 and
6 hours of LPS treatment, but not prior to LPS treatment when
TTP is expressed only at low levels (compare lanes 5, 6 with 4).
The fraction of total cellular TTP that exists in complex with
hnRNP F appears to decrease over the time course (compare
hnRNP F in lanes 6 and 5 in Figure 2A, and TTP in lanes 6 and 5
versus 3 and 2 in Figure 2B). The hnRNP F antibody also detected
hnRNP H1 and/or hnRNP H2, two homologous proteins that
share 96% amino acid identity with each other and 70% amino
acid identity with hnRNP F [35]. hnRNP H protein(s) (we could
not distinguish between hnRNP H1 or hnRNP H2) likewise co-
purify with TTP from RAW cells (Figure 2A, lanes 5 and 6). By
contrast, the negative control RNA binding protein HuR did not
co-purify with TTP (lower panels), and hnRNP F and TTP did not
co-purify with non-specific antisera (Figures 2A and 2B, lanes 7–9).
Thus, TTP can be observed in an RNA-independent complex
with hnRNP F, and at least one of its close hnRNP H homologs,
under conditions in which TTP is induced in a macrophage cell
line. The absence of other tested RNA binding proteins from the
TTP/BRF1-hnRNP F/H complexes (Figures 1 and 2) validates
that these are RNA-independent interactions, although it cannot
be ruled out that interactions are bridged by additional proteins.
hnRNP F stimulates decay of an ARE mRNA that contains
multiple hnRNP F binding sites
To investigate whether hnRNP F affects TTP function, we first
tested the importance of hnRNP F for the degradation of an
mRNA substrate with multiple predicted binding sites for both
hnRNP F and TTP. In vitro binding studies have identified the
sequence DGGGD (where D is A, G or U) as a consensus binding
site for hnRNP F and hnRNP H proteins [36]. The 494-nucleotide
39UTR of BRSK1 mRNA contains a 37-nucleotide ARE with two
nonameric predicted high affinity TTP binding sites
(UUAUUUAUU; and a total of three AUUUA sequences) flanked
upstream and downstream by thirteen DGGGD hnRNP F/H
consensus sites. The 39 UTR from the BRSK1 mRNA was
inserted into a b-globin reporter mRNA, replacing the existing
39UTR. The RNA-IP assays shown in Figure 3A verified that
hnRNP F and TTP both assemble with the BRSK1 39UTR, as the
b-BRSK1 mRNA is enriched with both Flag-hnRNP F (lanes 4
and 5) and Flag-TTP (lanes 6 and 7) over b-globin mRNA lacking
the BRSK1 39UTR (compare upper to lower bands; b-globin
mRNA contains a total of three DGGGD sequences). There was
minimal background binding of the tested mRNAs to the used
affinity beads (lanes 8 and 9).
We next tested whether hnRNP F and TTP/BRF proteins
affect the turnover of the b-BRSK1 mRNA by monitoring the
effect of siRNA-mediated knock-down of hnRNP F or TTP/BRF
proteins in pulse-chase b-BRSK1 mRNA decay assays in HeLa
Tet-Off cells. The b-BRSK1 mRNA was stabilized (P,0.01;
n = 6) following hnRNP F knockdown, degrading with a half-life of
123612 minutes as compared to 7766 minutes for cells treated
with the control siRNA (Figure 3B). Less than 11% of cellular
hnRNP F remained in the siRNA-treated cells, whereas hnRNP H
levels were unaffected (Figure 3C). In contrast to hnRNP F,
depletion of hnRNP H showed only a minor effect on the half-life
of the b-BRSK1 mRNA (Figure S1). We were unable to test the
effect of co-depletion of hnRNP F and hnRNP H proteins because
this double knockdown impaired cell growth (data not shown).
Following treatment with a previously characterized siRNA
targeting all three TTP/BRF family proteins [37] the b-BRSK1
mRNA was stabilized and degraded with a half-life of 220643
minutes (Figure 3B). Thus, hnRNP F stimulates the degradation of
an exogenous TTP/BRF-target ARE-mRNA containing multiple
binding sites for hnRNP F and TTP.
The stimulation of TTP/BRF-target mRNA degradation by
hnRNP F does not correlate with the extent of hnRNP F
mRNA binding
Given the observed complex formation of hnRNP F with TTP
and BRF1 (Figures 1 and 2), it was possible that the concentration
of hnRNP F on mRNAs dictates its ability to stimulate TTP/BRF-
mediated mRNA degradation. Alternatively, the relationship
could be more complex, depending for example on the position(s)
of hnRNP F binding within the mRNA or on other aspects of
mRNP composition. We therefore tested whether hnRNP F
stimulates the degradation of TTP/BRF-target mRNAs predicted
to have less binding to hnRNP F than the BRSK1 39UTR. We
replaced the BRSK1 39UTR with the AREs from GMCSF and
TNFa mRNAs, which are well-characterized targets of TTP
[3,38–40], thereby reducing the number of hnRNP F/H
Figure 2. hnRNP F complexes with TTP/BRF1 in LPS-stimulated
RAW macrophages. (A) Western blots for endogenous proteins that
co-IP with anti-TTP (lanes 4–6) or pre-immune sera (lanes 7–9) from
RNase-treated extracts of RAW264.7 cells stimulated with 100 ng/ml
LPS for the indicated times. Precipitates are compared with 1% of the
input (lanes 1–3). The anti-hnRNP F/H antibody recognizes both hnRNP
F (bottom band) and hnRNP H proteins (top band). (B) Same as panel A,
except the IP was performed with anti-hnRNP F/H (lanes 4–6) or anti-
Myc (lanes 7–9).
doi:10.1371/journal.pone.0100992.g002
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consensus sites to only those found in the b-globin mRNA
reporter. As expected, these ARE-reporter mRNAs are not
enriched over b-globin mRNA lacking an ARE in IPs for hnRNP
F (Figure S2 and data not shown). Nevertheless, as seen in
Figures 4A and B, b-globin mRNAs containing the AREs from
GMCSF (Figure 4A) or TNFa (Figure 4B) are both stabilized
following knockdown of hnRNP F. Depletion of hnRNP F also
stabilized a b-globin mRNA containing the entire 39UTR from
TNFa mRNA (Figure 4C). This 39UTR contains nine hnRNP F/
H consensus sites, but we detected no enrichment for TNFa
mRNA over GAPDH mRNA in hnRNP F/H IP assays from
RAW cells (Figure S3). From these experiments we conclude that
the ability of hnRNP F to stimulate the decay of TTP/BRF-target
mRNAs does not correlate simply with the number of hnRNP F/
H consensus binding sites and the extent of hnRNP F mRNA
binding, suggesting a more complex mechanism than concentra-
tion-dependent recruitment.
hnRNP F associates with a subset of endogenous TTP-
target ARE mRNAs and stimulates LIF mRNA decay in NIH
3T3 cells
We next wished to test whether hnRNP F stimulates degrada-
tion of endogenous TTP substrate mRNAs. These experiments
were performed in NIH 3T3 fibroblast cells, which express TTP
upon stimulation with serum [41]. NIH 3T3 cells were chosen for
these experiments because siRNA-mediated knockdowns were
more efficient in this cell line than in RAW cells (data not shown).
As seen in Figure 5A, TTP and BRF1 proteins are induced in NIH
3T3 cells following serum addition after starvation, with TTP
protein levels peaking at 2 to 4 hours and BRF1 induced at 2 to
6 hours.
To first test whether hnRNP F can be found associated with
endogenous TTP substrate mRNAs, RNA-IP experiments were
performed in NIH 3T3 cells stimulated with serum for two hours.
Bound mRNAs were assayed by quantitative (q)RT-PCR and
enrichment was determined as the ratio of bound ARE mRNA
over GAPDH mRNA, since the co-purification of GAPDH
mRNA with the antibody against hnRNP F was the lowest of any
of the tested mRNAs (Figure 5B). We specifically monitored for
TTP target mRNAs determined from global mRNA decay
analyses in TTP2/2 mouse embryonic fibroblasts [24] and from
TTP IPs [22,23]. All of the tested ARE mRNAs contain three or
more 39UTR AUUUA sequences and, as expected, were all
enriched in TTP IPs over GAPDH mRNA, which contains no
AUUUA motifs (Figure S4). As seen in Figure 5B, RNA-IPs from
NIH 3T3 cells uncovered a subset of TTP-target mRNAs that
were enriched over GAPDH mRNA with the antibody against
hnRNP F. These include TTP, LIF, IER3 and BRF1 mRNAs.
The hnRNP F antibody does not discriminate between hnRNP F
and hnRNP H1/H2 (Figure 2), so it cannot be ruled out that some
mRNAs were specifically associated with one or the other of these
hnRNPs. By contrast, cFOS, PLK3, and MLLT11 mRNAs were
not enriched over GAPDH mRNA with the hnRNP F antibody
(Figure 5B). The observed enrichment of individual mRNAs with
hnRNP F/H correlates well with the number of hnRNP F/H
consensus sites in the mRNA 39UTRs, with enriched mRNAs
Figure 3. hnRNP F binds to and stimulates the decay mediated
by the BRSK1 ARE-containing 39UTR. (A) Northern blot showing
reporter mRNAs that co-precipitate with transiently expressed Flag-
tagged hnRNP F (lanes 4, 5), TTP (lanes 6, 7), or empty vector (lanes 8, 9)
in HEK 293T cells. Precipitates and 5% of total extract (lanes 1–3) were
probed for the presence of b-globin and b-BRSK1 mRNAs. Bottom, A
cartoon schematic of the b-BRSK1 mRNA reporter with the 39UTR from
BRSK1 gene containing an ARE (black bar) and G-rich sequence repeats
(grey bars) downstream of the b-globin coding region. (B) Northern
blots showing mRNA decay of the b-BRSK1 mRNA reporter in HeLa Tet-
off cells transfected with siRNAs targeting hnRNP F, TTP/BRF1/BRF2
(TTP/BRF), or luciferase (Luc.) as indicated. Numbers above lanes refer to
times in minutes after transcriptional shut-off by tetracycline addition
(Chase). Levels of the reporter mRNA was normalized to the
constitutively expressed b-globin control mRNA and the average half-
life (t1/2) and the standard error of the means was determined from 6
independent experiments. P-value was calculated with Students t-test
(paired two-tailed). (C) HeLa Tet-Off cells were transfected with the
corresponding siRNAs and knockdown of hnRNP F was assessed by
Western Blot. Upf1 served as a loading control. Numbers above lanes
with Luc siRNA samples refer to the percent of extract loaded.
doi:10.1371/journal.pone.0100992.g003
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containing 10–48 consensus sites compared with 1–7 in those not
enriched over GAPDH (Figure 5B, bottom).
Next, decay rates of a subset of the tested mRNAs were
measured in NIH 3T3 cells by quantitative (q)RT-PCR at time
points following treatment with the global transcription inhibitor
Actinomycin D, added three hours after serum stimulation. LIF,
IER3, and cFOS mRNAs were monitored in these assays, since
these mRNAs reached maximal induction and clearance during
this time course (data not shown). LIF mRNA was stabilized (P,
0.05) upon hnRNP F knockdown and degraded with a half-life of
8766 minutes compared to 6664 minutes for the control siRNA
treatment (Figure 5C left panel; knockdown efficiency shown in
Figure 5D). LIF mRNA was also stabilized using two other
independent hnRNP F siRNAs (Table S1). As expected, knock-
down of TTP/BRF proteins also stabilized LIF mRNA, to a half-
life of 8363 minutes (Figure 5C).
In contrast to LIF mRNA, another TTP-target mRNA
encoding IER3 did not appear to be stabilized following hnRNP
F knockdown (Figure 5C, middle panel) with a measured half-life
of 5366 minutes compared to 5069 minutes for the control
siRNA treatment. As expected, knockdown of TTP/BRF proteins
stabilized IER3 mRNA, degrading with a half-life of 75612
minutes (P,0.1). Thus, hnRNP F appears to be limiting for only a
subset of TTP-target mRNAs, and, as also observed with reporter
mRNAs in Figure 4, the extent of hnRNP F mRNA association
does not correlate with the ability to stimulate decay (compare
Figures 5B and 5C). cFOS mRNA (Figure 5C, right panel) served
as a negative control for TTP-mediated mRNA decay; although
cFOS mRNA contains AREs and is bound by TTP, TTP is not
limiting for cFOS mRNA decay [24]. As expected, cFOS mRNA
decay was unaffected after TTP/BRF or hnRNP F knockdown.
Taken together, we conclude that hnRNP F forms an RNA-
independent complex with TTP and BRF1 proteins and stimulates
the degradation of a subset of TTP/BRF-target mRNAs.
Discussion
The regulation of ARE-mRNAs by TTP and its family
members is complex and not well understood. For example,
much remains unknown about how TTP and BRF1 identify and
bind to substrate mRNAs, and how their RNA decay activity is
executed and regulated. To address these questions we sought to
identify proteins that interact with TTP and BRF1 and might
serve as TTP/BRF1 co-factors. Two proteins, hnRNP F and
CAD, were identified to complex at high levels with TTP and
BRF1 in a RNA-independent manner (Figures 1 and 2). Given its
previously established role in mRNA regulatory events we focused
our study on hnRNP F and found that it stimulates the
degradation of a subset of TTP/BRF1-target mRNAs (Figures 3–
5). Stimulation of TTP/BRF1-target mRNA decay did not
correlate with the extent of hnRNP F mRNA binding (Figures 3–
5), indicating a more complex mechanism than simple concentra-
tion-dependent recruitment. Taken together, our observations
identify a new component of TTP/BRF-complexes, which serves
as a co-factor in a subset of TTP/BRF-mediated decay events.
Figure 4. hnRNP F stimulates the decay of TTP/BRF-target
mRNAs that show low binding to hnRNP F. (A) Northern blots
showing mRNA decay of the b-GMCSF-ARE mRNA reporter in HeLa Tet-
off cells transfected with siRNAs targeting hnRNP F or luciferase (Luc.) as
indicated. Levels of reporter mRNA was normalized to the constitutively
transcribed control mRNA (b-GAP mRNA) and half-life (t1/2) and
standard error of the mean was determined from two independent
experiments. Cartoon of the b-ARE mRNA reporter with the ARE from
GMCSF inserted in the 39 UTR is shown below the panel. (B) Same as
panel A, but monitoring the decay of a reporter mRNA containing the
ARE from the TNFa mRNA. Average half-life and standard error of the
mean was calculated from two independent experiments. (C) Same as
panel A, but monitoring decay of the b-TNFa mRNA reporter,
containing the entire 39 UTR of TNFa mRNA. Average half-life and
standard error of the mean was calculated from 4 independent
experiments.
doi:10.1371/journal.pone.0100992.g004
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The specific mechanism by which hnRNP F stimulates TTP/
BRF1-mediated decay, and how it interfaces with other TTP/
BRF co-factors, is an important question for future study. Given
that hnRNP F is a sequence-specific member of the hnRNP class
of RNA-binding proteins that are abundant components of
mRNPs, an interesting possibility is that TTP/BRF mRNA-target
specificity is dictated in part by the hnRNP composition of the
mRNP. If true, this could help explain why TTP/BRF proteins act
on only a subset of ARE-containing mRNAs [24]. Our
observations showed no correlation between the ability of hnRNP
F to stimulate ARE-mRNA decay and the number of predicted
hnRNP F binding sites or the extent of hnRNP F mRNA binding
(Figures 3–5). Thus, the mechanism by which hnRNP F stimulates
TTP/BRF-mediated degradation is likely more complex, and
could depend for example on the position of hnRNP F binding
within the mRNA or other aspects of mRNP structure or
composition. Future studies should reveal whether the position
of hnRNP F binding relative to the ARE or other mRNA elements
is important, or whether additional mRNP components facilitate
the communication between hnRNP F and TTP/BRF proteins.
Given that the hnRNP F-TTP/BRF complex is resistant to
RNase, it is also possible that hnRNP F stimulates TTP/BRF
proteins through mechanisms that do not require direct RNA
binding by hnRNP F. hnRNP F could stimulate TTP/BRF
Figure 5. hnRNP F stimulates decay of the endogenous TTP-target LIF mRNA in NIH 3T3 cells. (A) Western blots showing levels of TTP,
BRF1, and HuR in NIH 3T3 cells incubated with serum for the indicated time after 24 hours of serum starvation. (B) Quantification of the enrichment
relative to GAPDH mRNA of known TTP-target mRNAs (listed below the graph) that co-precipitate with an antibody against hnRNP F/H from extracts
of NIH 3T3 cells incubated for 2 hours with serum after 24 hours of serum starvation. mRNA levels were determined by qRT-PCR. The fold enrichment
for each ARE-mRNA was calculated by dividing the level of ARE-mRNA relative to that of GAPDH mRNA in each IP sample, after subtracting
background levels from IP reactions with anti-Myc. Indicated standard error of the mean values were calculated from three experiments. Asterisks
represent P-values ,0.1 (*) and P-value ,0.05 (**). The number of hnRNP F/H consensus binding sites (DGGGD) within the 39 UTR of each mRNA is
listed below the graph. (C) mRNA decay assays for LIF, cFOS, and IER3 mRNAs in NIH 3T3 cells transfected with 80 nM of the indicated siRNAs and
incubated for 3 hours in full media after 24 hours of serum starvation. Samples were collected at 0, 40, 80, and 120 minutes after addition of 10 mg/ml
Actinomycin D. ARE mRNA was normalized to GAPDH mRNA by qRT-PCR to determine relative abundance and to calculate mRNA decay half-lives.
Average half-life, standard error of the mean and P-values for LIF and cFOS were determined from three biological repeat experiments and two
biological repeats for IER3. (D) Western blots showing depletion of hnRNP F and TTP in NIH 3T3 cells transfected with 80 nM of the indicated siRNA
and incubated with serum for 0 or 2 hours after 24 hours of serum starvation. PABP serves as a loading control.
doi:10.1371/journal.pone.0100992.g005
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activity as part of the TTP/BRF complex for example by affecting
the ability of TTP/BRF proteins to recruit mRNA decay factors,
to remodel the mRNP in preparation for mRNA degradation, or
by influencing TTP/BRF regulation by phosphorylation. We
observed a consistent - albeit moderate - reduction in the fraction
of cellular TTP that complexes with hnRNP F over time of
stimulation of RAW macrophages with LPS (Figure 2). Given that
TTP is regulated by phosphorylation and dephosphorylation
events during a time course of LPS stimulation, this reduction in
hnRNP F association with TTP could signify that the interaction is
modulated by phosphorylation. Alternatively, the dramatic
increase in TTP levels that occurs during LPS stimulation could
render the cellular levels of hnRNP F limiting for the interaction.
The remodeling of mRNPs that takes place to allow mRNA
degradation is generally associated with repression of translation
initiation [46] and hnRNP F has previously been implicated in
translational repression [33,34,47]; thus, an important question for
future study is whether this activity of hnRNP F plays a role in
TTP/BRF-mediated degradation of ARE-mRNAs.
Finally, hnRNP F and TTP/BRF proteins are present at high
levels in the nucleus of some cell types [42–45], and hnRNP F has
been shown to modulate pre-mRNA splicing and polyadenylation
[31,32]. Thus, the effect of hnRNP F on TTP/BRF function could
be mediated by a nuclear interaction. Such an interaction could
affect mRNA degradation by TTP/BRF proteins specifically in
the nucleus, or affect the downstream activity of TTP/BRF
proteins in the cytoplasm. Future studies should reveal the
dynamics of the TTP/BRF-hnRNP F interaction and how it
relates with other TTP/BRF co-factors. Here we focused on the
most abundant TTP/BRF-associated proteins that could be
observed by silver staining of RNase-treated TTP/BRF complex-
es; however, TTP/BRF proteins also assemble with less abundant
factors, including many factors involved in translation repression
and mRNA degradation [4–7]. An important goal of future study
is to dissect the dynamics of the TTP/BRF complexes to
understand how they control the translation and degradation of
a specific subset of ARE-mRNAs in a manner regulated by
phosphorylation events.
Materials and Methods
Protein isolation and mass spectrometry
The preparation of stable T-REx HEK 293 cell lines expressing
FLAG-tagged TTP or BRF1 under control of a tetracycline
regulated promoter, and subsequent protein expression, isolation
and mass spectrometry were conducted as described previously for
decapping factors [6].
Co-immunoprecipitation assays
RAW264.7 cells seeded in 15 cm plates were cultured in
DMEM/10% fetal bovine serum/1% penicillin and streptomycin.
100 ng/ml LPS (Sigma) was added to cells for 0, 2, or 6 hr and
cells were washed in PBS, pelleted, and lysed in 1.4 ml lysis buffer
(10 mM Tris-HCl pH 7.5, 10 mM NaCl, 2 mM EDTA, 0.1%
Triton X-100, 1 mM PMSF, 2 mg/ml aprotinin, 2 mg/ml
leupeptin) and incubated on ice for 5 min. NaCl was added to
150 mM and 15 ml RNase A (10 mg/ml) was added and
incubated on ice for 10 min. Cytoplasmic extract was collected
after a 15 min spin at 14,000 rpm at 4uC and incubated with
80 mg of Protein A sepharose (GE Healthcare Life Sciences, 17-
0780-01), in Net-2 buffer (50 mM Tris-HCl, 150 mM NaCl,
0.05% Triton X-100) conjugated to 4 mL of anti-TTP antibody
(Sigma, T5327) or pre-immune rabbit serum. For hnRNP F IPs,
an equivalent amount of Protein G sepharose was used with 4 ml
anti-hnRNP F/H antibody (Abcam, 1G11) or anti-Myc antibody
(Cell Signaling, 9B11). After 3 hrs rotating incubation at 4uC, the
precipitates were washed 8 times in Net-2 buffer and eluted in
50 ul of load buffer (100 mM Tris-HCl pH 6.8, 4% SDS, 0.2%
bromophenol blue, and 20% glycerol) to which 200 mM DTT
was added. Precipitated protein was analyzed by SDS-PAGE and
Western blotting.
Pulse chase mRNA decay assays
mRNA decay assays and Northern blotting were performed as
previously described [48]. HeLa Tet-off cells (Clontech) were
seeded to 12-well plates and cultured in DMEM/10% fetal bovine
serum/1% penicillin and streptomycin (full DMEM). siRNAs were
transfected at a final concentration of 20 nM using siLentFect
Lipid Reagent (Bio-Rad) following the manufacturers protocol.
Then either: 1) 24 hours later, plasmid DNA was transfected in
the presence of 50 ng/ml tetracycline using TransIt HeLa-
Monster (Mirus), or 2) 48 hours later 20 nM siRNA was
transfected with plasmid DNA using Lipofectamine 2000 reagent
(Inivitrogen) in the presence of 50 ng/ml tetracycline. Two days
after plasmid transfection, transcription of the mRNA reporter was
activated for six hours with a PBS wash and replacement of full
DMEM without tetracycline. Six hours later, transcription was
shut off with addition of 1 mg/ml tetracycline. Cells were
harvested in Trizol (Invitrogen) for RNA extraction at subsequent
time points as indicated, with time ‘‘0’’ taken 20 minutes after
tetracycline addition. For each time course, one well of cells were
taken up in 2x SDS load buffer (100 mM Tris-HCl pH 6.8,
200 mM DTT, 4% SDS, 0.2% bromophenol blue, and 20%
glycerol) for protein analysis by SDS-PAGE and Western blot.
Endogenous NIH 3T3 cell mRNA decay assays
NIH 3T3 cells were seeded at,20% confluency in 10 cm plates
in full DMEM. 80 nM siRNA was transfected with TransIT TKO
(Mirus) reagent the next day. 24 hours later, cells were washed 3
times with PBS and trypsinized and re-plated at ,25% confluency
in DMEM/0.2% fetal bovine serum/1% penicillin and strepto-
mycin. 24–48 hours later cells were re-fed with DMEM/20% fetal
bovine serum/1% penicillin and streptomycin for 3 hrs and then
10 ug/ml Actinomycin D was added and cells were collected at
the indicated time points in Trizol (Invitrogen) for RNA
extraction.
RNA immunoprecipitation (RNA-IP) assays
NIH 3T3 cells were seeded at,20% confluency in 10 cm plates
in full DMEM. The following day cells were washed 3 times with
PBS and cultured in DMEM/0.2% fetal bovine serum/1%
penicillin and streptomycin. 24–48 hours later cells were re-fed
with DMEM/20% fetal bovine serum/1% penicillin and strepto-
mycin. Cells were collected for RNA-IP two hours later as
described for protein immunoprecipitation except that the lysis
buffer was supplemented with 14 ml yeast total RNA at 10 mg/ml,
1.4 ml RNaseOUT, and NaCl to 150 mM, and that RNase A was
not added to extracts. Immunoprecipitates were harvested in
Trizol (Invitrogen) for RNA extraction.
For RNA-IP assays from transiently transfected HEK 293T
cells, these were seeded at ,20% confluency on 10 cm plates in
full DMEM and transfected the following day with TransIT 293
transfection reagent (Mirus) and 5 mg pcDNA3-bwtb-BRSK1-
39UTR, 1 mg pcDNA3-bwtb mRNA reporter plasmid and either
4 mg pcDNA3-Flag-hnRNP F, or 500 ng pcDNA3-Flag-TTP and
3.5 mg pcDNA3-Flag plasmid. Two days later cell extracts were
collected for RNA-IP as described above for NIH 3T3 cells.
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Quantitative RT-PCR and oligos
3 ug total RNA was treated with DNase I (Invitrogen) and
reverse transcribed with either SuperScript II or III (Invitrogen)
following the manufacturers protocol. cDNA was used for qPCR
with SYBR Green PCR Master Mix (Applied Biosystems) and run
on an Applied Biosystems StepOnePlus Real-Time PCR System.
Gene expression levels were quantified relative to endogenous
GAPDH. P-values were calculated using Student’s t-test (paired
two tailed). The following oligos were used: TTP-F - cggaggactttg-
gaacataaac, TTP-R - ggagttgcagtaggcgaagtag, GAPDH-F -
catggccttccgtgttccta, GAPDH-R - cctgcttcaccaccttcttgat, LIF-F-
tgtgcaacaagtaccgtgtg, LIF-R- ttgcttgtatgtccccagaag, TNFA-F -
accttgtctactcccaggttctc, TNFA-R - gaggttgactttctcctggtatg, IL10-
F - tgctatgctgcctgctcttac, IL10-R – aagtgggtgcagttattgtcttc, USP46-
F - tgcttcaagcgctgtacttc, USP46-R - tgacgccaaccttcttcttc, KLHL2-
F - accaaaggctatccgaagtg, KLHL2-R – aagccaccaacagcaaagac,
IER3-F - gcgcgtttgaacacttctc, IER3-R- cagaagatgatggcgaacag,
cFOS-F - gaatggtgaagaccgtgtcag, cFOS-R - gtctccgcttggagtgtatc,
PLK3-F - ttgcgtcctacatggaacag, PLK3-R - actgaggatcagcttcgtgtg,
MLLT11-F - tattgccagcatccactctg, MLLT11-R - cagcaccaccagca-
caatag.
siRNAs
siRNAs were purchased from Dharmacon. Luciferase control
siRNA: 59-CGU ACG CGG AAU ACU UCG AUU-39+59-UCG
AAG UAU UCC GCG UAC GUU-39. mTTP siRNA: 59-GGA
GGA CUU UGG AAC AUA AUU -39+59- UUA UGU UCC
AAA GUC CUC CUU-39. mBRF1/2 (A) - 59- UGC CGC ACC
UUC CAC ACC ACA UU-39+59- UGU GGU GUG GAA GGU
GCG GCA UU -3. mBRF1/2 (B) - 59- CUA CAA GAC GGA
GCU GUG CCG UU-39+59- CGG CAC AGC UCC GUC UUG
UAG UU-3. Target sequences for the following siRNAs are:
human TTP/BRF1/2 – CGC UGC CAC UUC AUC CAC AAC
UU [37], hnRNP F (1) – AGU CAG AAG AUG AUG UAA A,
hnRNP F (2) – GGA AUG UAU GAC CAC AGA UUU, hnRNP
F (3) – UGA GAA AGC UUU AGG GAA G, hnRNP H – UAA
GCA GUA AGC GUA UUU A. siRNAs targeting Upf1 was
described previously [49].
Plasmid constructs
The BRSK1 39 UTR was PCR amplified from human genomic
DNA using the oligos – F - gga gaa GCGGCCGC TCC TGG
CCA CCA ACG GGA CC and R - gga gaa TCTAGA CGG
AAT CAG AGA CAC GGA CGC AGG. The amplicon was
restriction digested and ligated into the pcTET2-bwtb reporter
plasmid previously described [50] using NotI and XbaI restriction
enzymes. The TNFa 39 UTR was PCR amplified using the oligos,
F - gga gaa GCGGCCGC CGA ACA TCC AAC CTT CCC
AAA CGC, R - gga gaa CTGCAG GCT CCT CTC CAG CTC
TCT CCG, and restriction enzyme cloned into pcTET2-bwtb
plasmid with NotI and PstI. The b-GMCSF-ARE and b-TNFa-
ARE reporter plasmids were described previously [50]. The
pcDNA3-Myc-TTP and pcDNA3-Flag-TTP plasmids were de-
scribed previously [5]. hnRNP F was PCR amplified and
restriction digest inserted into pcDNA3-Myc and pcDNA3-Flag
using BamHI and NotI restriction sites.
Antibodies
The following antibodies were used: Rabbit polyclonal anti-
PABP (Abcam; ab21060), mouse monoclonal anti-hnRNP F/H
(Abcam, 1G11), mouse monoclonal anti-Myc-tag (Cell Signaling,
9B11), Upf1 rabbit polyclonal antisera [48], mouse monoclonal
anti-HuR (3A2) [51], and rabbit polyclonal anti-TTP-N-terminal
(Sigma, T5327).
Supporting Information
Figure S1 hnRNP H knockdown shows only minor
effects on the decay of reporter ARE-mRNAs. (A) Northern
blots showing mRNA decay of the b-BRSK1 mRNA reporter in
HeLa Tet-off cells transfected with an siRNA targeting hnRNP
H1 and H2 (referred to as hnRNP H). Levels of the reporter
mRNA was normalized to the constitutively expressed b-globin
control mRNA and the half-life (t1/2) was calculated. (B) Northern
blots showing mRNA decay of the b-TNFa-ARE mRNA reporter
in HeLa Tet-off cells transfected with an siRNA targeting hnRNP
H proteins. (C) Western blot showing a representative knockdown
of hnRNP H in HeLa Tet-off cells. hnRNP F knockdown is also
shown. Upf1 serves as a loading control.
(DOCX)
Figure S2 hnRNP F IP does not detectably enrich b-
GMCSF-ARE mRNA reporter over a control mRNA.
Northern blot showing reporter mRNA containing the ARE from
GMCSF mRNA, b-GMCSF-ARE, or control (b-GAP mRNA),
that co-precipitates with transiently expressed Flag-tagged hnRNP
F (lane 3) or TTP (lane 4) in HEK 293T cells. Precipitates and 5%
of total extract (lanes 1, 2) were probed for the presence of b-
globin mRNAs.
(DOCX)
Figure S3 hnRNP F/H IP does not enrich TNFa over
GAPDH mRNA. Quantification of the enrichment of TNFa
mRNA and LIF mRNA, relative to GAPDH (GAP) mRNA, in
immunoprecipitates with antibodies against TTP (left panel) or
hnRNP F/H (right panel) from extracts of RAW264.7 cells
stimulated with 100 ng/ml LPS for 2 hours. Below the graphs are
shown the number of ARE pentamer sequences (AUUUA; left
graph) and the number of hnRNP F consensus binding sites
(DGGGD; right graph) found within the 39 UTR of each mRNA.
Fold enrichment were determined from three biological repeats;
error bars represent standard error of the mean.
(DOCX)
Figure S4 Association of TTP with NIH 3T3 cell ARE
mRNAs. Quantification of the enrichment relative to GAPDH
(GAP) mRNA of known TTP-target mRNAs (listed below the
graph) that co-precipitate with an antibody against TTP from
extracts of NIH 3T3 cells incubated for 2 hours with serum after
24 hours of serum starvation. mRNA levels were determined by
qRT-PCR. The average-fold enrichment for each ARE-mRNA
was calculated from two biological repeats by dividing the level of
ARE-mRNA relative to that of GAPDH mRNA in each IP
sample, after subtracting background levels from IP reactions with
rabbit pre-immune serum; error bars represent standard error of
the mean. The number of ARE pentamer sequences (AUUUA)
within the 39 UTR of each mRNA is listed below the graph.
(DOCX)
Table S1 Summary of LIF mRNA decay in NIH 3T3
cells. The decay of endogenous LIF mRNA in siRNA-treated
NIH 3T3 cells is shown in the table. The decay rate after hnRNP
F depletion with two additional siRNAs, hnRNP F (2) and hnRNP
F (3), is shown. The mRNA decay rate represents the average half-
life 6 standard error of the mean from three biological repeats
(N= 3).
(DOCX)
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